Citi says buy the dip in Eli Lilly ahead of Alzheimer's drug launch

Published Wed, Sep 29 20216:36 AM EDTUpdated Wed, Sep 29 20217:16 AM EDT

Eli Lilly Pharmaceutical company logo

SOPA Images | LightRocket | Getty Images

The recent pullback in Eli Lilly's stock provides an attractive buying opportunity ahead of the company's Alzheimer's drug launch, Citi said.

NEXT PRO TALK

Wed, July 6 2022 - 12:00pm

Etsy shares will remain under pressure even after 60% pullback this year, Needham says

Needham upgrades Chewy, says shares can rally more than 40% because the pet space is defensive

Goldman Sachs says buy AutoZone, a 'defensively positioned' stock to weather inflation